Boston Scientific Recalls Heart Stents

Via the Boston Globe:

"Boston Scientific Corp. said yesterday it is recalling a large number of its drug-coated cardiac stents, which have been among the fastest-selling medical devices in history, after reports of a death and serious injuries related to the devices. . . ."

The recall is a serious stumble for Boston Scientific. The medical device firm grew into the state's biggest life sciences company over the past year, as its stock rose based on the potential of Taxus. The company says it has dethroned rival Johnson & Johnson as the leader in the $3 billion drug-coated stent market. So far, the two companies are the only ones with drug-coated stents on the market."

See a prior post about the stent wars here.